Search

Search Funnelback University

Search powered by Funnelback
31 - 40 of 62 search results for `Search news` |u:www-neurosciences.medschl.cam.ac.uk
  1. Fully-matching results

  2. New genetic clues point to new treatments for ‘silent’ stroke -…

    https://www-neurosciences.medschl.cam.ac.uk/blog/new-genetic-clues-point-to-new-treatments-for-silent-stroke/
    23 Feb 2024: Department of Clinical Neurosciences. Featured news. New genetic clues point to new treatments for ‘silent’ stroke. ... This is the most extensive genetic search to date which truly gets to grips with what cause lacunar strokes.
  3. EMA announces temporary restriction on alemtuzumab prescribing -…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/ema-announces-temporary-restriction-on-alemtuzumab-prescribing/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. EMA announces temporary restriction on alemtuzumab prescribing. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.
  4. Scientists identify first genetic marker for MS severity - Department …

    https://www-neurosciences.medschl.cam.ac.uk/blog/scientists-identify-first-genetic-marker-for-ms-severity/
    23 Feb 2024: Site Search. Scientists identify first genetic marker for MS severity. ... Department of Clinical Neurosciences. Featured news. Scientists identify first genetic marker for MS severity.
  5. Apathy could predict onset of dementia years before other symptoms -…

    https://www-neurosciences.medschl.cam.ac.uk/blog/apathy-could-predict-onset-of-dementia-years-before-other-symptoms/
    23 Feb 2024: Site Search. Apathy could predict onset of dementia years before other symptoms. ... Department of Clinical Neurosciences. Featured news. Apathy could predict onset of dementia years before other symptoms.
  6. Long term follow-up from phase 3 alemtuzumab trials: 11-13 years…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/long-term-follow-up-from-phase-3-alemtuzumab-trials-11-13-years-after-first-dosing/
    23 Feb 2024: Coles Ther Adv Neurol Disord 2023, Vol. 16: 1–16. Filed Under: News. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.
  7. Leading Cambridge neuroscientist appointed as Executive Chair of…

    https://www-neurosciences.medschl.cam.ac.uk/blog/leading-cambridge-neuroscientist-appointed-as-executive-chair-of-medical-research-council/
    23 Feb 2024: Site Search. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council. ... Department of Clinical Neurosciences. Featured news. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council.
  8. MS Society Press Release on the bexarotene trial - Cambridge Clinical …

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/ms-society-press-release-on-the-bexarotene-trial/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. MS Society Press Release on the bexarotene trial. ... Site Search. Recent Posts. Categories. For people with MS. 2024 University of Cambridge.
  9. Promising molecule targets protein to offer hope for people with…

    https://www-neurosciences.medschl.cam.ac.uk/blog/promising-molecule-targets-protein-to-offer-hope-for-people-with-parkinsons/
    23 Feb 2024: Site Search. Promising molecule targets protein to offer hope for people with Parkinson’s. ... Department of Clinical Neurosciences. Featured news. Promising molecule targets protein to offer hope for people with Parkinson’s.
  10. Drug incorporated into silicone coating reduces ‘foreign body…

    https://www-neurosciences.medschl.cam.ac.uk/blog/drug-incorporated-into-silicone-coating-reduces-foreign-body-reaction-to-implants/
    23 Feb 2024: Site Search. Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants. ... Department of Clinical Neurosciences. Featured news. Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants.
  11. Clinical trial for new stem cell-based treatment for Parkinson’s…

    https://www-neurosciences.medschl.cam.ac.uk/blog/clinical-trial-for-new-stem-cell-based-treatment-for-parkinsons-disease-given-go-ahead/
    23 Feb 2024: Site Search. Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead. ... Department of Clinical Neurosciences. Featured news. Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead.

Refine your results

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.